Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$2.92
-2.18%
Mkt Cap $6.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$1.50 | -$18.50 | -1133.33% | — | — |
| Q4 2025 Nov 6, 2025 | — | — | — | -$2.00 | -$1.75 | +12.50% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.23 | -$0.25 | -8.70% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.77 | -$0.30 | +61.04% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.92 | -$0.74 | +19.57% | — | — |
| Q4 2024 Oct 30, 2024 | — | — | — | -$1.00 | -$1.03 | -3.00% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.98 | -$1.01 | -3.06% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$1.18 | -$1.11 | +5.93% | — | — |
| Q1 2024 Mar 29, 2024 | — | — | — | -$1.60 | -$0.24 | +85.00% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.10 | -$1.60 | -1500.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$3.00 | -$2.00 | +33.33% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$5.60 | -$3.60 | +35.71% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$5.00 | -$7.00 | -40.00% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$6.80 | -$7.40 | -8.82% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$0.20 | -$6.40 | -3100.00% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$4.80 | -$4.00 | +16.67% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$3.60 | -$4.20 | -16.67% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$4.20 | -$3.80 | +9.52% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$3.00 | -$4.00 | -33.33% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.10 | -$2.80 | -2700.00% | — | — |